Characteristics, clinical outcomes and patient-reported outcomes of patients with ulcerative colitis receiving tofacitinib: a real-world survey in the United States and five European countries

Peer Review reports

Original Submission
7 Sep 2022	Submitted	Original manuscript
10 Nov 2022	Reviewed	Reviewer Report
13 Nov 2022	Reviewed	Reviewer Report
7 Dec 2022	Author responded	Author comments - Axel Dignass
Resubmission - Version 2
7 Dec 2022	Submitted	Manuscript version 2
9 Dec 2022	Author responded	Author comments - Axel Dignass
Resubmission - Version 3
9 Dec 2022	Submitted	Manuscript version 3
31 Dec 2022	Reviewed	Reviewer Report
Resubmission - Version 4
	Submitted	Manuscript version 4
Publishing
4 Jan 2023	Editorially accepted
19 Jan 2023	Article published	10.1186/s12876-023-02640-7

Back to article page